SARS-CoV-2 and probable lung cancer risk

[Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term co...

Descripción completa

Detalles Bibliográficos
Autores principales: Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124879/
https://www.ncbi.nlm.nih.gov/pubmed/35677665
http://dx.doi.org/10.34172/bi.2022.23266
_version_ 1784711823019212800
author Khiali, Sajad
Rezagholizadeh, Afra
Entezari-Maleki, Taher
author_facet Khiali, Sajad
Rezagholizadeh, Afra
Entezari-Maleki, Taher
author_sort Khiali, Sajad
collection PubMed
description [Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.
format Online
Article
Text
id pubmed-9124879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tabriz University of Medical Sciences (TUOMS Publishing Group)
record_format MEDLINE/PubMed
spelling pubmed-91248792022-06-07 SARS-CoV-2 and probable lung cancer risk Khiali, Sajad Rezagholizadeh, Afra Entezari-Maleki, Taher Bioimpacts Perspective [Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development. Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022 2022-03-26 /pmc/articles/PMC9124879/ /pubmed/35677665 http://dx.doi.org/10.34172/bi.2022.23266 Text en https://creativecommons.org/licenses/by-nc/4.0/ This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Perspective
Khiali, Sajad
Rezagholizadeh, Afra
Entezari-Maleki, Taher
SARS-CoV-2 and probable lung cancer risk
title SARS-CoV-2 and probable lung cancer risk
title_full SARS-CoV-2 and probable lung cancer risk
title_fullStr SARS-CoV-2 and probable lung cancer risk
title_full_unstemmed SARS-CoV-2 and probable lung cancer risk
title_short SARS-CoV-2 and probable lung cancer risk
title_sort sars-cov-2 and probable lung cancer risk
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124879/
https://www.ncbi.nlm.nih.gov/pubmed/35677665
http://dx.doi.org/10.34172/bi.2022.23266
work_keys_str_mv AT khialisajad sarscov2andprobablelungcancerrisk
AT rezagholizadehafra sarscov2andprobablelungcancerrisk
AT entezarimalekitaher sarscov2andprobablelungcancerrisk

Ejemplares similares